innorna

CN

NEWSROOM

ALL Press Release Awards Media Center

Press Release

2023. 02. 25

Innorna’s SARS-CoV-2 mRNA vaccine received FDA clearance for Phase I clincial trial

Awards

2023. 05. 23

CEO of Innorna, Dr. Li Linxian, on "2023 Science and Technology Entrepreneurs" List

Awards

2023. 06. 02

Innorna Awarded the Title of "Shenzhen Potential Technology Unicorn Enterprise"

Awards

2023. 04. 28

Innorna on "2022 China Healthcare Industry Investment and Financing Honor List"

Awards

2023. 05. 23

Innorna Honored to Be on “2022 CVAwards-Annual List”

Awards

2022. 08. 03

MIT technology Review -2021 TR50

Awards

2023. 04. 18

Innorna was listed on the 2023 “PEdaily Top 100 Sci-Tech Innovation Companies”

Press Release

2023. 02. 25

Innorna’s SARS-CoV-2 mRNA vaccine received FDA clearance for Phase I clincial trial

Awards

2023. 02. 02

Innorna ranked on 2022 Vigorous 100 List

Awards

2023. 01. 11

2022 VENTURE Sprouts List and 2022 PEdaily Healthcare VENTURE50

Press Release

2022. 12. 20

Innorna’s Covid mRNA Vaccine Approved by New Zealand for Phase I Clinical Trial

Awards

2022. 12. 02

WISE 2022 King of the New Economy-Enterprise of the Year - 36Kr

...02030405

innorna

TEL

+86 (0755) 8653 3681

+852 3520 2228


EMAIL

info@innorna.com

info.hk@innorna.com


ADDRESS

Shenzhen Office: 6/F, Tower B, Tsinghua Information Port, 1 Songping Mountain New East Road, Nanshan, Shenzhen

Hong Kong Office: Rm 222, 12 W Science and Technology West Avenue, Phase 3, HKSTP, Shatin, HKSAR

Nanjing Office: 5/F, Tower B, Phase 1, Zhongdan Eco-Life Science Industrial Park, Pukou, Nanjing

  • TECHNOLOGY
  • PIPELINE
  • ACHIEVEMENTS
  • ABOUT Innorna
  • INVESTORS AND PARTNERSHIP
  • NEWSROOM
  • JOIN US
  • CONTACT US

© 2025 Innorna Co. Ltd. ALL RIGHTS RESERVED

粤ICP备2020110996号
Designed by Sumaart